Study Type
Observational
ongoing
Atrial fibrillation (AF) is a very common co-morbidity in patients with heart failure (HF). In patients with HF but with no prior history of clinically overt AF, subclinical AF of one hour or greater in duration is common (>10% of patients) and is associated with an increased risk of HF hospitalization.
The SCAF-HF study will aim to identify this subclinical AF to see whether it has impact on patient hospitalizations for heart failure.
Study Design
Multicentre, prospective cohort
NO. of Countries
1
NO. of Sites
5
NO. of Participants
1014
Study Period
2020 - 2022
Sponsor
PHRI
Jorge Wong
Scientist
Jorge Wong
Scientist
Jorge Wong is a cardiologist and cardiac electrophysiologist at Hamilton Health Sciences, as well as a scientist in the Arrhythmia and Heart Failure program at PHRI. His research interests focus primarily on the intersection between atrial fibrillation and heart failure, atrial fibrillation epidemiology and catheter ablation for atrial fibrillation. He holds research grants from the Heart and Stroke Foundation of Canada, the Canadian Cardiovascular Society, and Hamilton Health Sciences.
He obtained his MD at McMaster, followed by his internal medicine and cardiology training at the University of Western Ontario. Jorge subsequently completed his clinical electrophysiology fellowship at the University of Calgary and at the Brigham and Women’s Hospital in Boston. He has a Master of Public Health degree from the Harvard School of Public Health, and is currently pursuing his PhD in Health Research Methods at McMaster.
Tara McCready
Program Director
Tara McCready
Program Director
Tara McCready, PhD, oversees a variety of collaborative programs at PHRI, and serves as Project Manager for PHRI research studies and registries.
She was recruited to PHRI as a Program Director for the Canadian Network and Centre for Trials Internationally (CANNeCTIN), a national network funded by the CIHR/CFI Clinical Research Initiative program to improve the prevention and treatment of cardiac and vascular diseases and diabetes.
Previously the Executive Director of the Canadian Maternal, Infant, Child and Youth Research Network, Tara holds a PhD in Biochemistry and a MBA in Technology Commercialization from the University of Alberta.
Alex Grinvalds
Project Manager
Alex Grinvalds
Project Manager
Alex Grinvalds has more than 15 years experience in clinical research, of which 13 have been at PHRI. He has worked on randomized studies, device trials and numerous registries. Currently, Alex is working on studies involving patients with heart failure and arrhythmias.
Alex holds a Bachelor of Science degree from Queen’s University and a Certificate in Clinical Research from Humber College.
PHRI Internal Grant
Heart and Stroke Foundation
ongoing
PROTECT-HF
Arrhythmia & Heart Failure
Heart failure (HF) is the leading cause of hospitalization in patients older than 65 years...
